Chronic Obstructive Pulmonary Disease (COPD) - Wake Research

Chronic Obstructive Pulmonary Disease (COPD)

pictured: a man clutches his chest with one hand and coughs into his fist

COPD Research Study

Tucson Neuroscience Research is comparing two inhaler treatments on patients with Moderate to Severe COPD with cardiovascular disease or risk.

To qualify, you must:

  • Be 40-80 years old
  • Have Moderate to Severe COPD without an exacerbation within 8 weeks and no history of Asthma lifetime or lung cancer within 5 years
  • History of smoking
  • No history of Asthma
  • No history of Lung Cancer
  • Have pre-existing CVD or high-risk CVD conditions (Hypertension, Diabetes, Obesity, etc.)

Qualified participants may receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • May receive compensation for time
pictured: a man clutches his chest with one hand and coughs into his fist

Why Participate?

Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.


The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.


Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Tucson Neuroscience Research

Study Hotline

Main Office

Our Hours
Mon-Fri: 8am-4:30pm

Our Address
6567 E. Carondelet Drive
Suite 455
Tucson, AZ 85710-2156